Istaroxime is a first‐in‐class agent which acts through inhibition of the sarcolemmal Na⁺/K⁺ pump and activation of the SERCA2a pump. This study assessed the effects of a 24 h infusion of istaroxime in patients hospitalised for acute heart failure (AHF).

中文翻译：

---

接受急性心力衰竭住院的患者接受24小时异羟肟酸输注治疗：一项随机，安慰剂对照试验。

Istaroxime是一流的药物，通过抑制肌膜Na ⁺ / K ⁺泵和激活SERCA2a泵起作用。这项研究评估了在急性心力衰竭（AHF）住院患者中24小时输注异羟肟酸的效果。